Perceptive Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-590,000
| Closed | -$5.4M | – | 91 |
|
|
2023
Q1 | $5.4M | Buy |
+590,000
| New | +$5.4M | 0.16% | 74 |
|
|
2020
Q3 | – | Sell |
-8,681
| Closed | -$133K | – | 128 |
|
|
2020
Q2 | $133K | Hold |
8,681
| – | – | ﹤0.01% | 122 |
|
|
2020
Q1 | $76K | Hold |
8,681
| – | – | ﹤0.01% | 108 |
|
|
2019
Q4 | $66K | Buy |
+8,681
| New | +$66K | ﹤0.01% | 108 |
|
|
2018
Q2 | – | Sell |
-1,295,841
| Closed | -$9.45M | – | 129 |
|
|
2018
Q1 | $9.45M | Sell |
1,295,841
-1,096,000
| -46% | -$7.99M | 0.26% | 61 |
|
|
2017
Q4 | $19.6M | Buy |
2,391,841
+842,836
| +54% | +$6.91M | 0.65% | 41 |
|
|
2017
Q3 | $16.3M | Buy |
1,549,005
+119,891
| +8% | +$1.26M | 0.62% | 38 |
|
|
2017
Q2 | $15.8M | Buy |
1,429,114
+20,874
| +1% | +$230K | 0.79% | 36 |
|
|
2017
Q1 | $13.6M | Buy |
1,408,240
+20,000
| +1% | +$194K | 0.78% | 34 |
|
|
2016
Q4 | $14.4M | Buy |
1,388,240
+24,529
| +2% | +$255K | 1.03% | 25 |
|
|
2016
Q3 | $16.9M | Buy |
+1,363,711
| New | +$16.9M | 1.09% | 21 |
|
|
2015
Q1 | – | Sell |
-644,111
| Closed | -$3.68M | – | 148 |
|
|
2014
Q4 | $3.68M | Buy |
644,111
+34,111
| +6% | +$195K | 0.31% | 62 |
|
|
2014
Q3 | $8.73M | Sell |
610,000
-190,000
| -24% | -$2.72M | 0.88% | 28 |
|
|
2014
Q2 | $12M | Hold |
800,000
| – | – | 1.18% | 27 |
|
|
2014
Q1 | $10.7M | Buy |
+800,000
| New | +$10.7M | 1.13% | 27 |
|